Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$127.77 - $221.42 $1.04 Million - $1.8 Million
8,117 New
8,117 $1.76 Million
Q2 2023

Aug 04, 2023

BUY
$272.48 - $330.23 $359,128 - $435,243
1,318 New
1,318 $380,000
Q4 2022

Feb 02, 2023

SELL
$212.22 - $313.46 $659,155 - $973,606
-3,106 Reduced 87.86%
429 $126,000
Q3 2022

Nov 04, 2022

BUY
$224.6 - $281.45 $793,961 - $994,925
3,535 New
3,535 $810,000
Q2 2022

Aug 03, 2022

SELL
$186.4 - $279.02 $40,821 - $61,105
-219 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$194.8 - $275.7 $42,661 - $60,378
219 New
219 $58,000
Q1 2021

Apr 26, 2021

SELL
$235.95 - $293.05 $118,446 - $147,111
-502 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$215.97 - $265.89 $108,416 - $133,476
502 New
502 $128,000
Q3 2020

Oct 14, 2020

SELL
$192.55 - $236.59 $622,899 - $765,368
-3,235 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$159.17 - $224.73 $234,934 - $331,701
1,476 Added 83.91%
3,235 $628,000
Q1 2020

Apr 29, 2020

BUY
$130.01 - $216.44 $228,687 - $380,717
1,759 New
1,759 $291,000
Q4 2019

Feb 05, 2020

SELL
$144.81 - $186.0 $3,330 - $4,278
-23 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$117.35 - $167.95 $2,699 - $3,862
23 New
23 $3,000
Q2 2019

Jul 26, 2019

SELL
$82.13 - $120.73 $163,849 - $240,856
-1,995 Closed
0 $0
Q1 2019

Apr 18, 2019

BUY
$72.44 - $101.87 $144,517 - $203,230
1,995 New
1,995 $0
Q3 2018

Oct 23, 2018

SELL
$81.43 - $108.13 $256,748 - $340,933
-3,153 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$83.27 - $101.93 $262,550 - $321,385
3,153 New
3,153 $270,000
Q4 2017

Jan 10, 2018

SELL
$55.67 - $71.8 $144,352 - $186,177
-2,593 Closed
0 $0
Q3 2017

Oct 25, 2017

BUY
$49.68 - $59.46 $128,820 - $154,179
2,593
2,593 $142,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.